Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?-Reference-Cited by-同舟云学术

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?

Published:2022-05 Issue: Volume:106 Page:102392
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Cejalvo Juan Miguel,Falato Claudette,Villanueva Lorea,Tolosa Pablo,González Xavier,Pascal Mariona,Canes Jordi,Gavilá Joaquín,Manso Luis,Pascual Tomás,Prat Aleix,Salvador Fernando

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference140 articles.

1. Cancer immunotherapy;Couzin-Frankel;Science,2013

2. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N Engl J Med,2018

3. LBA16 KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC;Cortés;Ann Oncol,2021

4. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial;Cortes;Lancet,2020

5. VP7-2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC;Schmid;Ann Oncol,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?;Vaccines;2024-06-28

2. Oncolytic virus-based combination therapy in breast cancer;Cancer Letters;2024-03

3. Unveiling Strategies to Conquer Virus-Induced Breast Cancer Drug Resistance;Overcoming Breast Cancer Therapy Resistance;2024

4. Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers;International Journal of Molecular Sciences;2023-10-18

5. Breast cancer immunotherapy: a comprehensive review;Clinical and Experimental Medicine;2023-09-01